Self-amplifying RNA Pandemic Influenza Vaccine

self-amplifying RNA influenza vaccine · Arcturus Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Self-amplifying RNA Pandemic Influenza Vaccine, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults [Phase 1]